Zobrazeno 1 - 10
of 147
pro vyhledávání: '"Frank I. Carroll"'
Autor:
Anita H. Lewin, Frank I. Carroll, Eric C. Peterson, Samantha J. McClenahan, Melinda G. Gunnell, Samuel M. Owens, Pamela Lamb, Chad M. Kormos, Michael D. Hambuchen
Publikováno v:
Vaccine
α-PVP (α-pyrrolidinovalerophenone) and MDPV (3,4-methylenedioxypyrovalerone) are potent abused stimulants that are members of the synthetic cathinone class of drugs. Although these drugs are taken with recreational intent, high doses can lead to un
Autor:
Carla Hassler, Paul R. Pentel, Marco Pravetoni, Federico Baruffaldi, Frank I. Carroll, Michael D. Raleigh, Scott P. Runyon, S. J. King, S. Winston, Angela K. Birnbaum, Michaela J. Roslawski
Publikováno v:
Mol Pharm
This study focused on formulating conjugate vaccines targeting oxycodone and heroin for technology transfer, good manufacturing practice (GMP), and clinical evaluation. Lead vaccines used the highly immunogenic carrier protein keyhole limpet hemocyan
Autor:
Melinda G. Gunnell, Bruce E. Blough, Hambuchen, Jackson O. Lay, Cowell Jl, Rachel Tawney, Eric C. Peterson, Frank I. Carroll, Samuel M. Owens
Publikováno v:
Bioconjugate Chemistry
Control of small molecule hapten epitope densities on antigenic carrier proteins is essential for development and testing of optimal conditions for vaccines. Yet, accurate determination of epitope density can be extremely difficult to accomplish, esp
Autor:
Sandra D. Comer, Samantha J. Peterson, Federico Baruffaldi, Marco Pravetoni, Scott P. Runyon, Megan Laudenbach, Michael D. Raleigh, S. Winston, Paul R. Pentel, Frank I. Carroll, Tiffany L. Langston, Hernán A. Navarro
Publikováno v:
PLoS ONE, Vol 12, Iss 12, p e0184876 (2017)
PLoS ONE
PLoS ONE
Among vaccines aimed at treating substance use disorders, those targeting opioids present several unique medication development challenges. 1) Opioid overdose is a common complication of abuse, so it is desirable for an opioid vaccine to block the to
Publikováno v:
British Journal of Pharmacology. 169:567-579
Background and Purpose The α7 nicotinic ACh receptor subtype is abundantly expressed in the CNS and in the periphery. Recent evidence suggests that α7 nicotinic ACh receptor (nAChR) subtypes, which can be activated by an endogenous cholinergic tone
Autor:
Hiroshi Nagase, Xi Ping Huang, Jian Jin, Jing Liu, Bryan L. Roth, John D. McCorvy, Frank I. Carroll, Tao Che, Katherine Lansu, Joel Karpiak, Wesley K. Kroeze, Brian K. Shoichet
Publikováno v:
Nature chemical biology, vol 13, iss 5
Nature chemical biology
Nature chemical biology
The primate-exclusive MRGPRX2 G protein-coupled receptor (GPCR) has been suggested to modulate pain and itch. Despite putative peptide and small molecule MRGPRX2 agonists, selective nanomolar potency probes have not yet been reported. To identify a M
Autor:
Jeffrey S. Stehouwer, Heather L. Kimmel, Ronald J. Voll, Leonard L. Howell, John R. Votaw, Mark M. Goodman, Frank I. Carroll, Jiyoung Mun, Jonathon A. Nye
Publikováno v:
Synapse. 66:501-508
Several classes of drugs bind to the dopamine transporter (DAT) with high affinity, but some are weaker positive reinforcers than cocaine, suggesting that affinity for and occupancy of the DAT is not the only determinant of a drug's reinforcing effec
Autor:
Scott P. Runyon, Daniel E. Keyler, Ramakrishna R. Pidaparthi, Frank I. Carroll, Paul R. Pentel, Marco Pravetoni, C. A. Earley, Michael P. Murtaugh
Publikováno v:
Biochemical Pharmacology. 83:543-550
Nicotine conjugate vaccine efficacy is limited by the concentration of nicotine-specific antibodies that can be reliably generated in serum. Previous studies suggest that the concurrent use of 2 structurally distinct nicotine immunogens in rats can g
Autor:
Juan Pablo Cueva, Frank I. Carroll, Scott P. Runyon, James B. Thomas, Hernán A. Navarro, S. W. Mascarella
Publikováno v:
ACS Medicinal Chemistry Letters. 1:365-369
This report describes the discovery that 1-substituted 4-(3-hydroxyphenyl)piperazines are pure opioid receptor antagonists. Compounds in this new series include N-phenylpropyl (3S)-3-methyl-4-(3-hydroxyphenyl)piperazine and (3R)-3-methyl-4-(3-hydroxy
Publikováno v:
Vaccine. 33(46)
Therapeutic vaccines for nicotine addiction show pre-clinical efficacy. Yet, clinical evaluation of the first-generation nicotine vaccines did not meet expectations because only a subset of immunized subjects achieved effective serum antibody levels.